CLINICAL_TRIALS
ClinicalTrials.gov record update
AVELUMAB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED AVELUMAB CLINICAL STUDIES.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05059522
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-10-21T00:02:23.853601+00:00
- Published At
- 2026-10-20T00:00:00+00:00
- Record Updated At
- 2026-10-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Advanced Malignancies", "NSCLC", "Ovarian Cancer", "Urothelial Cancer", "Solid Tumors"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-10-20"- protocolSection.identificationModule.nctId
"NCT05059522"- protocolSection.identificationModule.officialTitle
"AVELUMAB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED AVELUMAB CLINICAL STUDIES."- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.